Cohort (LSE:CHRT) has been showing high-beta share price behaviour. The Reading-based defence technology group has just delivered record results and a €140.7 million submarine sonar order, yet its shares have swung sharply as sentiment towards UK defence spending has changed.

Cohort plc has been showing high-beta characteristics. Beta is a historical statistic showing how much a share has tended to move relative to a benchmark; a reading above 1 means larger swings than the market in both directions. It describes the past, not future returns.

Cohort owns seven defence businesses spanning naval sonar, communications, electronic warfare and surveillance. It is quoted on AIM and, sits in the FTSE AIM 100, FTSE AIM UK 50 and FTSE AIM All-Share indices. The interest now lies in the gap between strong company-level trading and a share price that has been buffeted by political news on defence budgets.

Why Cohort Is in Focus

Market data on 24 September 2026 showed a one-year beta of about 1.6, a share price of 1,180p and a Market Value of roughly £544 million. The same data showed the shares up about 28% in 2026 to date but down around 13% over one year, having peaked at 1,796p on 16 July 2025.

The timing is also notable: Cohort's Annual General Meeting was scheduled for 3pm on 24 September 2026 in London.

What Does Cohort Do?

Cohort reports through two divisions. Communications and Intelligence includes EID in Portugal, Australian satellite terminal maker EM Solutions, MASS and MCL. Sensors and Effectors includes Chess Dynamics, German sonar specialist ELAC SONAR and SEA.

The UK MOD accounted for 40% of Revenue in 2025/26, down from 50% a year earlier and, according to the company, the lowest share since Cohort was founded twenty years ago.

What Has Been Happening Recently?

On 23 March 2026 EM Solutions won an AU$21.7 million (about £11.5 million) order to Supply satellite communication terminals to the Portuguese Navy, and on 26 March EID secured a €42.3 million Portuguese Navy communications contract. A full-year trading update on 27 May said revenue and profit would be ahead of market expectations.

On 14 August Cohort announced that ELAC had been awarded a €140.7 million contract to work with Saab on integrated sonar systems for Poland's Orka submarine programme, with deliveries running to the mid-2030s. The company said the order, alongside other recent wins, was expected to enhance adjusted Earnings Per Share from the following financial year.

Two weeks later, on 28 August, reports emerged that Chancellor John Healey would shelve his target of spending 3% of GDP on defence by 2030 in his first Budget. UK defence shares fell the same day following those reports.

What Are the Numbers Saying?

For the year to 30 April 2026, revenue rose 13% to a record £306.4 million and adjusted operating profit climbed 32% to £36.3 million. Adjusted earnings per share increased 14% to 61.9p and statutory profit before tax was £32.6 million. Order intake of £314.2 million again exceeded revenue, lifting the closing order book to a record £618.8 million.

Net funds were £2.2 million, reversing £32.5 million of net Debt at 31 October 2025. The total Dividend rose 10% to 17.90p, and Cohort renewed its banking Facility at £175 million with a £50 million accordion. Management said the order book covered 83% of market revenue expectations for 2026/27, rising to 88% after post-year-end wins, and reiterated its aim of double-digit earnings growth in each of the next three years.

Why Is the Share Price Attracting Attention?

The facts are that Cohort has delivered record results, a growing order book and a major export order, while the shares remain below their July 2025 high and have moved sharply within the year.

One possible interpretation is that Cohort's valuation has become tied to the broader defence-spending narrative as much as to its own trading. When government policy appears supportive, defence stocks can attract momentum buying; when targets look likely to slip, as the August reports suggested, the sector can be sold as a group. Some investors may view Cohort's rising export mix, with Poland, Portugal and Australia prominent, as a partial buffer against UK budget decisions. Others may focus on the Sensors and Effectors division, where revenue was flat and profit slightly lower in 2025/26.

With a market value around half a billion pounds, flows into or out of defence-themed funds can also have a noticeable effect on the price.

How Does the FTSE AIM All-Share Context Matter?

The FTSE AIM All-Share contains many smaller, less liquid companies whose shares tend to react more strongly to changes in risk appetite than those of large Main Market groups. Cohort (LSE:CHRT) is one of AIM's larger constituents but remains exposed to sector-wide swings.

There is no evidence that moves in the AIM index itself drove Cohort's share price. The more visible influences have been company announcements and UK defence policy headlines, which affect listed defence names regardless of market.

What Could Investors Watch Next?

Several scheduled and company-specific events may shape sentiment in the months ahead:

  • AGM: any trading commentary around the 24 September 2026 meeting, where shareholders were due to vote on the final dividend.
  • Dividend payment: the 12.10p final dividend is due to be paid on 2 October 2026 to shareholders on the register at 21 August.
  • UK Budget: the Chancellor's first Budget, reported to be due on 28 October, and what it says about funding the Defence Investment Plan.
  • Half-year results: interims for the six months to 31 October 2026, expected around December based on last year's 10 December release.
  • Order flow: further export contracts and progress on the Orka programme.

The Bottom Line

Cohort's high-beta profile reflects how sharply its shares have moved relative to the market, not a verdict on the business. Operationally, 2025/26 was a record year, with higher profit, net funds restored, a £618.8 million order book and a significant Saab-led submarine sonar contract in August. The share price, however, has been pulled by wider forces, notably shifting expectations for UK defence spending. What matters next is whether export orders keep growing, whether the Sensors and Effectors division recovers, and what the October Budget signals for UK procurement. Beta remains backward-looking.